Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics - Wikidata - awgldk - TriplyDB

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

http://www.wikidata.org/entity/Q34285662

about

Predicting the risk of psychosis onset: advances and prospects Iron insufficiency compromises motor neurons and their mitochondrial function in Irp2-null mice Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis Monitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinic Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study Knowledge transfer via classification rules using functional mapping for integrative modeling of gene expression data A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening Application of machine learning to proteomics data: classification and biomarker identification in postgenomics biology.Abnormal expression of homeobox genes and transthyretin in C9ORF72 expansion carriers Intricate effects of primary motor neuronopathy on contractile proteins and metabolic muscle enzymes as revealed by label-free mass spectrometry.Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia.Neuroproteomics: an insight into ALS.Plasma peptide biomarker discovery for amyotrophic lateral sclerosis by MALDI-TOF mass spectrometry profiling Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.Hepatic but Not CNS-Expressed Human C-Reactive Protein Inhibits Experimental Autoimmune Encephalomyelitis in Transgenic Mice.A Pilot Trial of Pioglitazone HCl and Tretinoin in ALS: Cerebrospinal Fluid Biomarkers to Monitor Drug Efficacy and Predict Rate of Disease Progression.Learning Parsimonious Classification Rules from Gene Expression Data Using Bayesian Networks with Local Structure.Functional classification of skeletal muscle networks. II. Applications to pathophysiology.Retinoid signaling alterations in amyotrophic lateral sclerosis.Measurement of cystatin C functional activity in the cerebrospinal fluid of amyotrophic lateral sclerosis and control subjects.Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis.Transfer learning of classification rules for biomarker discovery and verification from molecular profiling studies U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease.An empirical workflow for genome-wide single nucleotide polymorphism-based predictive modeling Increased Expressions of Plasma Galectin-3 in Patients with Amyotrophic Lateral Sclerosis.How can we improve clinical trials in amyotrophic lateral sclerosis?Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.Proteomic identification of biomarkers of skeletal muscle disorders.Integrative biomarker discovery in neurodegenerative diseases.Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis.Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.Zebrafish brain proteomics reveals central proteins involved in neurodegeneration.Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Proteomic profiling of the spinal cord in ALS: decreased ATP5D levels suggest synaptic dysfunction in ALS pathogenesis.Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics.Impaired activation of ALS monocytes by exosomes.Delivery of an anti-transthyretin Nanobody to the brain through intranasal administration reveals transthyretin expression and secretion by motor neurons.Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study.

P2860

Q27011694-B7A4B348-27CF-47CB-8AAE-E814758AD768 Q27318323-567B117A-207E-44E6-B369-C8D75BF8B81C Q28476466-CBA00356-4417-4E9B-851B-6B72FBD7F3C8 Q28483618-42FF183C-5E6C-4891-81C8-C9F9A36F8DB0 Q28600936-8759D617-7757-4100-BD75-9BA5DA567C56 Q28646636-AA450295-3245-41EA-AB1F-934BDC5C22E0 Q30511822-D7B90A81-8099-48E8-990B-7D2113FDAE67 Q30676067-5D9F3098-A357-46C4-855F-05CD92B7B3AE Q33821516-64E74813-3C36-4F6A-9575-C58BE5692672 Q33827791-C7ED136A-6AE1-4513-85BB-2726E5359BB5 Q34469280-464F3F63-9A93-4F2B-AA93-04E7A72A3071 Q34475101-D20B043A-69D4-4514-8C2E-8D7DD54EB050 Q35041471-D87AD137-6AC2-4D5B-84D7-611152630E2C Q35854192-424698F5-1EC3-4F66-B122-75497A0E1D50 Q36068653-3FD4DBAD-29A5-435A-88D3-17EDAADEAEA5 Q36090794-F579BC08-98C1-4DA1-BCB7-C4B673FD817E Q36319173-7FE00187-2190-412E-8DF1-84AF8413ADA4 Q36530917-AC19705C-0EAF-4A22-ADD9-D4DE887F520B Q36576439-54E882F0-8212-4FC9-8D87-B700AC47A15D Q36722418-7AF8C6D2-13EF-44B0-9CD9-241D5D8910E1 Q36953434-1BCA644C-2FE5-44B4-8B27-5D7CE06B86CB Q36996151-D5CDD26E-5AF7-4331-B2EE-560707366265 Q37236333-52892FED-AC18-425B-B931-5A58B3F160C6 Q37271395-E0580B97-1E49-4FFD-BDD0-9FDC6D91FCD8 Q37487611-5EB0E9B6-2D2E-435B-95F9-39BE259E99F6 Q37938694-7EAFB0C6-5A0D-4F77-9563-489E6110EB67 Q37944427-C7A529BB-C21F-45A3-A22D-8D2D0695F32E Q38079622-1E63D3E9-628E-448B-B308-E5C90F6204A3 Q38542025-132186C5-57E3-45B9-9878-747265DEF817 Q38643847-A322A24E-945F-4534-8064-1F2A34798C32 Q39033841-163C039A-E2A0-4A5B-B22C-51F083F6C53D Q40981383-A2380403-9E38-4C53-B953-A3DD2147AE66 Q44085138-9211EF0A-FD71-44F6-810F-6036AE983657 Q46282864-334B5D8C-658E-4F06-BA94-F5E324259788 Q47587631-4A0AF426-3320-4154-B82D-F801DFE15B59 Q48412910-02044FCB-16DF-44EE-80AB-2CA9CE51E03C Q51071299-597BFDA7-2D8F-49BB-B237-4172A1E6CB8F Q51519602-F859B7C1-CA0B-4717-9189-ED0025DFEBE1 Q52661451-0E0FCDA6-8951-4950-A063-AE55EEA660F3 Q55502760-0317F5C1-2320-4FD3-8905-0DD3AE755A9C

P2860

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

http://www.wikidata.org/entity/Q34285662

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

@ast

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

@en

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

@nl

type

label

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

@ast

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

@en

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

@nl

prefLabel

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

@ast

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

@en

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

@nl

P1433

Q34285662-57F24539-607C-4720-A871-23729AAD6C91

P1476

Q34285662-1DC0805E-8615-4E56-BBFC-7A6BA48F3374

P2093

Q34285662-167C4197-7060-48A2-8E41-FD5F5DE07B1B

Q34285662-1DE97094-7ED1-4D33-8B87-0C2C0B9B09BE

Q34285662-2BA6D6A8-F42C-4D9D-B551-40A75BB9B97F

Q34285662-4B629E3E-E0ED-4DC9-A7FD-DE7DBEE2B706

Q34285662-5490B09A-6810-4427-B4DE-BBC7114923D8

Q34285662-FCE4E132-FF33-4A34-B1CB-563F02A336A8

P2860

Q34285662-02FFE5C1-ACEE-42EA-91E3-98C54BF4697E

Q34285662-0BCD3C9E-5F4D-4B58-BA7C-F077597EBC79

Q34285662-12498337-3087-429B-A1A1-5F62B99993A8

Q34285662-166F1C38-1FE7-429C-A8CD-F9FC6EC1063C

Q34285662-1E18AD5B-DD5B-4CBF-8B60-D763D5CAEBE9

Q34285662-205A0669-01A7-4072-88FC-BB4623A6FC0D

Q34285662-469CBBB6-4408-4584-9449-DBD4F21AE2D6

Q34285662-47001EFC-28B4-48E5-9467-687184DDC52B

Q34285662-48397D88-8CD6-4120-A8EA-4D1799FE89F9

Q34285662-4EED5F60-BCCB-4E0E-8603-7D62075382F3

P304

Q34285662-8F8040E7-47AD-4532-AE1D-6C8B39C9EA28

P31

Q34285662-E7CF456E-C49D-4D9C-8C91-69A1A01882BA

P356

Q34285662-7C97E542-0562-4326-90DE-509A76A9E37C

P433

Q34285662-16F109E7-9D3C-4814-B16B-F7F7B45A9131

P478

Q34285662-95BBD513-BA9C-4629-9C41-4B05F58EA382

P50

Q34285662-1A12BAE0-8580-4606-897B-80F7BD4652AE

Q34285662-C040C7C5-1765-4397-9BE6-96A47B699747

Q34285662-C740F0D8-C06D-49E6-93CE-DF43416984D6

P577

Q34285662-C94197A4-BAEF-4D1E-AF02-03D760901FF2

P5875

Q34285662-8FC23FBF-1A49-45F8-BFAE-AF592D45940F

P698

Q34285662-ADDFBFC1-C49F-4BF4-BB01-7C06FDC3BA47

P921

Q34285662-7E00F6C1-DB83-46CB-8C69-90C411796E7B

Q34285662-8999718A-67CE-480E-B78D-CCE16A4953FD

P932

Q34285662-9B7A86BD-4BF5-46B1-8B0B-D752800D2A84

P356

P1433

Muscle and Nerve

P1476

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

@en

P2093

David Lacomis

http://www.w3.org/2001/XMLSchema#string

Jiyan An

http://www.w3.org/2001/XMLSchema#string

Jonathan Llyle Lustgarten

http://www.w3.org/2001/XMLSchema#string

Matt Jaffa

http://www.w3.org/2001/XMLSchema#string

Robert Bowser

http://www.w3.org/2001/XMLSchema#string

Samuel Darko

http://www.w3.org/2001/XMLSchema#string

P2860

Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis

Cystatin C modulates cerebral beta-amyloidosis

Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

Amyloid formation in rat transthyretin: effect of oxidative stress.

Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment.

Gene deletion of cystatin C aggravates brain damage following focal ischemia but mitigates the neuronal injury after global ischemia in the mouse.

Inflammatory protein profile during systemic high dose interleukin-2 administration.

Identification of potential CSF biomarkers in ALS.

Differential post-translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid.

P304

104-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MUS.21683

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

Vanathi Gopalakrishnan

Merit E Cudkowicz

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44804831

http://www.w3.org/2001/XMLSchema#string

P698

20583124

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

2975276

http://www.w3.org/2001/XMLSchema#string